Indian Vaccines sent Worldwide

 Call it 'Vaccine Diplomacy' or any other name. It is undeniably the moment when you need to step forward to help. India is just doing it. Over the years, Indian pharmaceutical industries have built a solid foundation to excel in the production of drugs, vaccines, etc. Probably this is the moment it makes a world impact.

Nepal, Bangladesh, Brazil, Morocco, Myanmar, Seychelles, Mauritius, Bhutan, Mongolia, Maldives, Oman, Sri Lanka, Afghanistan have already received or in the process of receiving the COVID-19 vaccines, on is a renamed version of AstraZeneca and the other an Indian produced vaccine.

https://in.news.yahoo.com/india-sends-covid-vaccines-nepal-175925413.html

Partnering with WHO and UNICEF training ("The key topics covered were COVID-19 disease and vaccines, conducting COVID-19 vaccination, logistics and cold chain management, safe injection practices and waste management,' ") in administering COVID-19 was also provided for some of these countries.

More recently vaccines will be provided to Saudi Arabia and UAE.

https://www.msn.com/en-us/news/world/saudi-arabia-brazil-set-to-get-vaccines-as-india-begins-exports/ar-BB1cYd8N?ocid=uxbndlbing

https://gulfnews.com/uae/vaccine-maitri-indias-coordinated-efforts-to-fight-covid-19-1.1611578739605

More on vaccines to Africa:

https://southasiamonitor.org/india/after-neighbourhoold-india-sends-coronavirus-vaccines-morocco-africa

Even some European countries are seeking Indian made vaccines:

https://www.bloomberg.com/news/articles/2021-01-20/u-k-belgium-among-nations-seeking-cheaper-indian-vaccines

Watch this Video:

Dr. Krishna Ell's interview regarding the Bharth Biotech's Vaccine

 Bharath Biotech has law behind it for emergency use in India. It is the Phase 3's efficacy that is being questioned.  The vaccine has been undergoing peer review in journals with three of them already reviewed. The company is kosher as they have developed vaccines for Ebola, HiN1, Chikungunyay, etc.

Watch this Video.

More COVID-19 vaccines from India

 

There are 7 vaccines in India that may contribute to controlling the COVID-19 threat. Zydus will be coming with two different types.

 Here is a list. Follow the link at the end of the post for more details.

1. Covaxin - Bharath Biotech

2. Zydus Cadila's (2) -ZyCoV-D

3. AstraZeneca

4. Biological E        -from Hyderabad, Feb 2021

5. Mynvax -from Bengaluru's IISC based research. Recombinant type

6. Gennova -from Pune, mRNA type, Probably March 2021

Here is a full list:

https://timesofindia.indiatimes.com/life-style/health-fitness/health-news/coronavirus-vaccines-in-india-heres-a-list-of-all-covid-19-vaccines-made-in-india/photostory/79463339.cms

India begins its massive vaccination program on January 16

The first ones to get the vaccine are the front-line workers estimated at 30 million. The second group to follow are people above the age of 50 and those below the age of 50 with co-morbidity. The second group is estimated at 270 million. I am sure the AADHAR project will be of immense use.

https://timesofindia.indiatimes.com/india/all-india-vaccine-rollout-set-for-next-week-govt/articleshow/80123824.cms

https://timesofindia.indiatimes.com/india/covid-19-vaccination-drive-to-kick-off-on-jan-16-govt/articleshow/80187668.cms

Read more at:

http://timesofindia.indiatimes.com/articleshow/80187668.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

Read more at:

http://timesofindia.indiatimes.com/articleshow/80187668.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

https://www.ibtimes.com/india-start-mammoth-vaccination-drive-january-16-3118013

It is noteworthy that an Indian Pharmaceutical  (Bharat Biotech)

company could develop a vaccine in record time to address the emergency.

Covaxin, the Indian Vaccine for COVID-19 uses a traditional technique for vaccine development

 

https://www.bharatbiotech.com/covaxin.html

"U.S. biopharmaceutical firm Ocugen and Bharat Biotech have signed a binding letter of intent (LOI) to co-develop India’s COVID-19 vaccine candidate Covaxin for the United States market.....

----------

Covaxin offers a vaccine candidate that is different from other options currently available in the U.S. market with potentially broader coverage against multiple protein antigens of the virus,” said Harvey Rubin of the University of Pennsylvania and a member of Ocugen’s Vaccine Scientific Advisory Board."

The above extracted from:

https://www.thehindu.com/business/bharat-biotech-ocugen-to-take-covaxin-to-us/article33397081.ece